EventsEventsPodcasts
Loader
Find Us
ADVERTISEMENT

Private equity firm poised to sweeten UDG bid after investor opposition

Private equity firm poised to sweeten UDG bid after investor opposition
Copyright 
By Reuters
Published on Updated
Share this articleComments
Share this articleClose Button

- Private equity firm Clayton, Dubilier & Rice (CD&R) was planning to increase its offer to buy UDG Healthcare to 2.72 billion pounds ($3.79 billion), the London-listed company said on Friday, following investor opposition to a previously agreed bid.

Ireland-based UDG said the potential 1,080 pence per share offer would be CD&R's final, adding that it plans to recommend the proposal. In May, both the companies had agreed to a 1,023 pence per share offer.

While UDG's board backed the first offer, its largest shareholder Allianz Global Investors said last month the bid was "opportunistic and significantly undervalues UDG and its prospects".

Activist investor Elliott took a stake in UDG weeks after the first offer was made, while media reports said investor M&G was also not in favour of CD&R's previous proposal.

UDG said on Friday it had not received any other buyout proposals.

($1 = 0.7182 pounds)

Share this articleComments

You might also like